Home Page About Location Contact  Sitemap
Greek  
 
 
 

Service Units

  Biomedical Applications Unit
  Environmental Toxicology Unit
  Industrial Enzymology Unit
   
   

 


Biomedical Applications Unit

The Unit's team

Vassilis Zoumpourlis,PhD Research Associate Professor
Ioannis Christodoulou,PhD Post-Doctoral Research Fellow
Dimitrios Volanis PhD student
Stella Logotheti PhD student
Nikolas Houri Diploma Âiology student
Ageliki Papadopoulou Diploma Âiology student
Alexandra Lykoudi Diploma Âiology student
Georgia Kaprou Visiting Chemical Engineering student

Objectives (research directions)
The Biomedical Applications Unit launched its activity in 1996 and for over a decade has been specialized in exploiting the basic research results disclosed by the IBRB for the development of biomedical products and services applicable to the field of in vitro diagnostics. It has recently extended its activities towards the research of stem cells and their applications in cancer therapeutics, in terms of a fruitful collaboration with the TAK-EIE stem cell bank, an NHRF spin-off company. More specifically, the current aim is to characterize and compare the properties of human stem cell populations derived from different tissues and to establish the optimal candidates for cell-based treatment in various disease models, including cancer.

Human stem cell research
Stem cells are undifferentiated cells with a capacity for clonal expansion and differentiation into multiple functional cell types in vitro and in vivo. The research interests of BAU in the field of stem cells focus on the investigation of the mechanisms governing human post-natal stem cell differentiation in response to stimuli from their microenvironment and their potential use for regenerative medicine purposes. A second area of interest is the characterization and investigation of the differences in the biology of mesenchymal stem cell populations derived from different anatomical sites and developmental stages. Furthermore, the research team of BAU is investigating the use of these populations for cancer cytotherapy using in vitro and animal models.

Other research interests of the Unit aim at identifying new prognostic markers and therapeutic targets for cancer.


 
 

 

 

 

 
 

 

   
       

 

 
 
Research in the Unit
AP-1 transcription factors (mainly ATF-2) and steroid receptors in mouse skin carcinogenesis model
The study of the role of p73 isoforms in human lung cancer
The study of the role of Rho kinases in the progression and metastasis of cancer
Collaborative projects: the implication of kallikrein 6, Src oncoprotein, as well as the replication licensing factors hCdt1 and hCdc6 in malignancy

Last Update: 20.04.2011
© National Hellenic Research Foundation (NHRF), 48 Vassileos Constantinou Ave., 11635 Athens, Greece, Tel. +302107273700, Fax. +302107246618